|
⚲
|
| Keyboard |
| Tessier-Lavigne Marc
✚
|
|
|---|---|
| CIK # | 0001437435 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001437435] | |
| 4 | [0001437435] | |
| 5 | [0001437435] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tessier-Lavigne Marc | |
| Denali Therapeutics Inc | |
| Regeneron Pharmaceuticals Inc | |
| Agios Pharmaceuticals Inc | |
| Juno Therapeutics Inc | |
| Pfizer Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2025-06-03 | Grant | 18,111 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-06-03 | Grant | 6,037 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2024-05-31 | Grant | 5,967 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2024-05-31 | Grant | 17,901 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2023-06-01 | Grant | 4,216 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2023-06-01 | Grant | 12,649 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2023-01-03 | Grant | 165 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2023-01-03 | Grant | 165 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 1,929 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 1,929 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2022-11-23 | Sell | 20,000 | $30.48 | 609,600 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2022-11-02 | Sell | 11,252 | $30.33 | 341,273 |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2022-11-01 | Sell | 8,748 | $30.20 | 264,190 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-10-03 | Option exercise | 3,612 | $413.33 | 1,492,948 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-10-03 | Sell | 3,612 | $718.00 | 2,593,416 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2022-10-03 | Option exercise | 3,612 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-09-30 | Sell | 3,428 | $698.00 | 2,392,744 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-09-30 | Option exercise | 3,428 | $413.33 | 1,416,895 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2022-09-30 | Option exercise | 3,428 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-09-29 | Sell | 16 | $686.89 | 10,990 |
| showing 20 of 200 most recent transactions | |||||